Answers are grounded in this paper and cite their sources.
Analysis reveals correlations between nAChR subunits and treatment response in cervical intraepithelial neoplasia, suggesting potential prognostic markers.
Clinical and morphological characteristics of rapidly progressive cervical neoplastic processes and their frequent combination with endometrial hyperplastic processes, endometriosis and functional ovarian cysts suggest that their development is based on disorders caused by sex hormones, realized through cell proliferation with impaired apoptosis. Objective. To determine the correlation between the relative gene expression levels of different nicotinic acetylcholine receptor (nAChR) subunits, as well as long non-coding RNAs and cervical intraepithelial neoplasia (CIN) of varying severity, and the duration of CIN I treatment. Patients and methods. The study included 100 patients who were subdivided into 5 groups: group 1 – control group (with healthy cervix) (n = 20); group 2 – patients with CIN I (n = 20); group 3 – patients with CIN I who received epigenetic therapy (n = 20), group 4 – patients with CIN II (n = 20), group 5 – patients with CIN III (n = 20). The study was aimed at finding the dependence of the relative gene expression levels of nAChR subunits and long non-coding RNAs (CASC2, HOTAIR, lnc-ROR and MALAT1) in neoplastic altered cervical cells on the duration of epigenetic therapy using a real-time PCR. Results. The highest relative expression levels of the α2, α10 and β4 subunits were recorded in the control group, the maximum expression levels of the β3 subunit were recorded in group 2, and the α4, α5 and α9 subunits were characterized by a gradual increase in expression levels in direct proportion to increasing CIN severity. The highest relative expression levels of the α-9 subunit were seen in myoma samples in group 2. The α6, β1, β2, β3, γ nAChR subunits could be the most probable candidates for the role of markers to assess the efficacy of epigenetic therapy, since the change in their expression was quite pronounced in patients in group 3 treated for CIN I. Conclusion. Both long non-coding RNAs and some nAChR subunits may be suitable as markers of CIN and treatment efficacy.
No takes yet. Share an insight, caveat, or question.
Леваков et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: